# IBUPROFEN AND DIPHENHYDRAMINE CITRATE
> **ANDA216204** · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2022-05-31
## Drug
- **FDA Application Number:** ANDA216204
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** IBUPROFEN AND DIPHENHYDRAMINE CITRATE
- **Generic name:** IBUPROFEN AND DIPHENHYDRAMINE CITRATE
- **Active ingredients:** DIPHENHYDRAMINE CITRATE; IBUPROFEN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Over-the-counter
- **Sponsor:** AUROBINDO PHARMA
- **Manufacturer:** KROGER COMPANY
- **First approval:** 2022-05-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216204)
---
*MORVS · CC0 1.0*